FDA Adverse Event Malfunction Summary report: N

COULTER® LH 750 HEMATOLOGY ANALYZER

MDR report key: 3241775 · Received July 22, 2013

Report

Report Number
1061932-2013-01535
Event Type
Malfunction
Date Received
July 22, 2013
Date of Event
June 26, 2013
Report Date
June 26, 2013
Manufacturer
BECKMAN COULTER
Product Code
GKZ
PMA / PMN Number
K011342
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THE FIELD SERVICE ENGINEER (FSE) OBSERVED A SMALL FLUID LEAK AT THE UPPER SHEATH RESTRICTOR. THE FSE NOTED THE FLUID LEAK CONSISTED OF DILUENT AND WAS CONTAINED WITHIN THE INSTRUMENT. THE FSE CLEANED THE FLUID SPILL AND REPLACED THE SHEATH RESTRICTOR TUBING TO RESOLVE THE FLUID LEAK ISSUE. SERVICE ACTIVITY PERFORMED WAS VERIFIED TO MEET THE SPECIFIED REQUIREMENTS PER ESTABLISHED PROCEDURES. THE INSTRUMENT CONFORMED TO THE MANUFACTURER'S PUBLISHED PERFORMANCE SPECIFICATIONS AND WAS RETURNED TO NORMAL OPERATION. (B)(4).

Description of Event or Problem · 1

THE CUSTOMER REPORTED APPROXIMATELY FIVE MILLILITERS OF CLEAR BLUE FLUID LEAKED UNDERNEATH THE INSTRUMENT INVOLVING THE COULTER LH 750 HEMATOLOGY ANALYZER. THE OPERATOR WAS WEARING PROPER PERSONAL PROTECTIVE EQUIPMENT (PPE) CONSISTING OF GLOVES, A LABORATORY COAT, AND FACE SHIELD AND DID NOT HAVE DIRECT CONTACT WITH THE FLUID. THERE WAS NO OPERATOR INJURY OR ADVERSE EFFECT ASSOCIATED WITH THIS EVENT. THERE WERE NO ERRONEOUS RESULTS GENERATED OR REPORTED. PATIENT RESULTS WERE NOT IMPACTED. THERE WAS NO PATIENT CONSEQUENCE ASSOCIATED WITH THIS EVENT. THE CUSTOMER CEASED OPERATION OF THE INSTRUMENT. A BECKMAN COULTER FIELD SERVICE ENGINEER (FSE) WAS DISPATCHED TO ASSESS THE INSTRUMENT. THE FACILITY HAS AN EXPOSURE CONTROL AND RISK MANAGEMENT PLAN IN PLACE FOR BIOHAZARD MATERIAL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
341414 COULTER® LH 750 HEMATOLOGY ANALYZER COUNTER, DIFFERENTIAL CELL GKZ BECKMAN COULTER NA NA

Patients

Seq Age Sex Outcome Treatment
1